StockWatch
·
Pharmaceuticals
AGM/EGM8 Sept 2026, 08:50 pm

Aarey Drugs & Pharma Announces 36th AGM on Sep 30, 2026

AI Summary

Aarey Drugs & Pharmaceuticals Ltd has issued a notice for its 36th Annual General Meeting (AGM) scheduled for September 30, 2026, at 3:00 PM. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company is circulating its Integrated Annual Report for the financial year 2025-26 along with the AGM notice to shareholders electronically. The report and notice are also available on the company's website. Key agenda items include the adoption of the audited financial statements for FY 2025-26, and the re-appointment of Mrs. Bina Ghatalia as a Director retiring by rotation. Approval of related party transactions is also on the agenda as special business.

Key Highlights

  • 36th AGM scheduled for September 30, 2026, via VC/OAVM.
  • Integrated Annual Report for FY 2025-26 to be presented.
  • Audited financial statements for FY 2025-26 for adoption.
  • Director Mrs. Bina Ghatalia up for re-appointment.
  • Approval of related party transactions is a special business item.